D. Arndts

524 total citations
27 papers, 414 citations indexed

About

D. Arndts is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D. Arndts has authored 27 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in D. Arndts's work include Neuroscience and Neuropharmacology Research (4 papers), Anesthesia and Sedative Agents (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). D. Arndts is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Anesthesia and Sedative Agents (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). D. Arndts collaborates with scholars based in Germany, Ukraine and Australia. D. Arndts's co-authors include H. Förster, Bernhard Heintz, R. Kirsten, G. Schultz, J. Hescheler, Dietmar Krautwurst, Rudolf Hammer, Oleg Krishtal, Ulyana Lalo and E. Habermann and has published in prestigious journals such as Biochemical and Biophysical Research Communications, CHEST Journal and Molecular Pharmacology.

In The Last Decade

D. Arndts

27 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Arndts Germany	12	89	79	70	63	50	27	414
John C. Krantz United States	14	87 1.0×	56 0.7×	67 1.0×	73 1.2×	77 1.5×	89	576
E Kirsten United States	11	88 1.0×	191 2.4×	64 0.9×	46 0.7×	31 0.6×	18	491
L. E. Martin United Kingdom	8	91 1.0×	64 0.8×	47 0.7×	34 0.5×	65 1.3×	11	495
Louis Wj Australia	14	133 1.5×	150 1.9×	30 0.4×	62 1.0×	80 1.6×	29	547
E. Nüesch Japan	13	93 1.0×	45 0.6×	37 0.5×	38 0.6×	74 1.5×	25	579
Jan Idvall Sweden	11	77 0.9×	69 0.9×	201 2.9×	73 1.2×	109 2.2×	22	529
A. Doenicke Germany	14	81 0.9×	75 0.9×	262 3.7×	74 1.2×	117 2.3×	73	678
Jesús Novalbos Spain	17	162 1.8×	101 1.3×	33 0.5×	73 1.2×	125 2.5×	47	795
A. Hayes United Kingdom	8	162 1.8×	85 1.1×	56 0.8×	93 1.5×	133 2.7×	15	599
L B Sheiner United States	7	132 1.5×	59 0.7×	38 0.5×	58 0.9×	93 1.9×	11	443

Countries citing papers authored by D. Arndts

Since Specialization

Citations

This map shows the geographic impact of D. Arndts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Arndts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Arndts more than expected).

Fields of papers citing papers by D. Arndts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Arndts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Arndts. The network helps show where D. Arndts may publish in the future.

Co-authorship network of co-authors of D. Arndts

This figure shows the co-authorship network connecting the top 25 collaborators of D. Arndts. A scholar is included among the top collaborators of D. Arndts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Arndts. D. Arndts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krishtal, Oleg, et al.. (2001). New channel blocker BIIA388CL blocks delayed rectifier, but not A-type potassium current in central neurons. Neuropharmacology. 40(2). 233–241. 6 indexed citations

Lalo, Ulyana, et al.. (2001). Ω-conotoxin GVIA potently inhibits the currents mediated by P2X receptors in rat DRG neurons. Brain Research Bulletin. 54(5). 507–512. 25 indexed citations

Tatlisumak, Turgut, Richard A.D. Carano, Kentaro Takano, et al.. (2000). Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat. Journal of the Neurological Sciences. 178(2). 107–113. 15 indexed citations

Krause, Elmar, et al.. (1998). LOE 908 Blocks Delayed Rectifier Type Potassium Channels in PC12 Cells and Cortical Neurons in Culture. Biochemical and Biophysical Research Communications. 244(3). 659–664. 8 indexed citations

Krautwurst, Dietmar, et al.. (1993). Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells.. Molecular Pharmacology. 43(5). 655–659. 56 indexed citations

Arndts, D., et al.. (1984). Pharmacokinetics and pharmacodynamics of transdermally administered clonidine. European Journal of Clinical Pharmacology. 26(1). 79–85. 50 indexed citations

Arndts, D.. (1983). New Aspects of the Clinical Pharmacology of Clonidine. CHEST Journal. 83(2). 397–400. 15 indexed citations

Arndts, D., et al.. (1983). New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man. European Journal of Clinical Pharmacology. 24(1). 21–30. 49 indexed citations

Harron, D. W. G., D. Arndts, & RG Shanks. (1982). Alinidine pharmacokinetics following acute and chronic dosing.. British Journal of Clinical Pharmacology. 13(6). 821–827. 11 indexed citations

10.

Arndts, D., et al.. (1981). Development of a RIA for clonidine and its comparison with the reference methods. Journal of Pharmacological Methods. 6(4). 295–307. 46 indexed citations

11.

Arndts, D. & H. Förster. (1981). New aspects in the metabolism of alinidine in man. European Journal of Drug Metabolism and Pharmacokinetics. 6(4). 313–315. 8 indexed citations

12.

Arndts, D., et al.. (1981). Proof of the linearity of the pharmacokinetics of alinidine in man. European Journal of Clinical Pharmacology. 21(3). 201–207. 21 indexed citations

13.

Arndts, D., G. Leb, & H. Förster. (1981). Pharmacokinetics and metabolism of14C-labelled alinidine in man an dogs. European Journal of Drug Metabolism and Pharmacokinetics. 6(3). 225–236. 6 indexed citations

14.

Arndts, D., et al.. (1979). A newly developed precise and sensitive radioimmunoassay for clonidine.. PubMed. 29(3). 532–8. 26 indexed citations

15.

Arndts, D., et al.. (1978). [Metabolite isolation for mass spectrometrical determination of new drugs (author's transl)].. PubMed. 28(11a). 1951–60. 2 indexed citations

16.

Rominger, K. L., et al.. (1977). Experimental investigation of possible cardiotoxic effects on the offspring of rats treated with high doses of fenoterol.. Journal of Perinatal Medicine. 5(5). 206–213. 4 indexed citations

17.

Pook, Karl‐Heinz, et al.. (1976). Mass Spectral Analysis of Glucuronides from Sympathomimetic Hydroxyphenylalkylaminoethanols. Journal of Pharmaceutical Sciences. 65(10). 1513–1518. 4 indexed citations

18.

Habermann, E., et al.. (1973). [Behavior of Trasylol in the body as a model for the pharmacokinetics of basic polypeptides].. PubMed. 24(29). 1163–7. 12 indexed citations

19.

Arndts, D., et al.. (1970). [Studies on the distribution and elimination of a proteinase inhibitor with isotope technics].. PubMed. 20(5). 667–74. 10 indexed citations

20.

Habermann, E., K. O. Räker, & D. Arndts. (1968). Radio-Retentionselektrophorese: ein quantitatives und spezifisches Verfahren zur Bestimmung einzelner Proteine im Nanogrammbereich. Journal of Molecular Medicine. 46(1). 46–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact